202 related articles for article (PubMed ID: 18820687)
1. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase.
Nowarski R; Britan-Rosich E; Shiloach T; Kotler M
Nat Struct Mol Biol; 2008 Oct; 15(10):1059-66. PubMed ID: 18820687
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G induces a hypermutation gradient: purifying selection at multiple steps during HIV-1 replication results in levels of G-to-A mutations that are high in DNA, intermediate in cellular viral RNA, and low in virion RNA.
Russell RA; Moore MD; Hu WS; Pathak VK
Retrovirology; 2009 Feb; 6():16. PubMed ID: 19216784
[TBL] [Abstract][Full Text] [Related]
3. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
4. Structure and real-time monitoring of the enzymatic reaction of APOBEC3G which is involved in anti-HIV activity.
Furukawa A; Nagata T; Matsugami A; Habu Y; Sugiyama R; Hayashi F; Kobayashi N; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2009; (53):87-8. PubMed ID: 19749273
[TBL] [Abstract][Full Text] [Related]
5. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G (APOBEC3G) and its family members on the activity of cellular microRNAs.
Zhang H
Prog Mol Subcell Biol; 2010; 50():71-83. PubMed ID: 19841882
[TBL] [Abstract][Full Text] [Related]
7. Single-stranded DNA scanning and deamination by APOBEC3G cytidine deaminase at single molecule resolution.
Senavirathne G; Jaszczur M; Auerbach PA; Upton TG; Chelico L; Goodman MF; Rueda D
J Biol Chem; 2012 May; 287(19):15826-35. PubMed ID: 22362763
[TBL] [Abstract][Full Text] [Related]
8. Model structure of human APOBEC3G.
Zhang KL; Mangeat B; Ortiz M; Zoete V; Trono D; Telenti A; Michielin O
PLoS One; 2007 Apr; 2(4):e378. PubMed ID: 17440614
[TBL] [Abstract][Full Text] [Related]
9. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
10. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3G encapsidation into HIV-1 virions: which RNA is it?
Strebel K; Khan MA
Retrovirology; 2008 Jul; 5():55. PubMed ID: 18597677
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair.
Nowarski R; Wilner OI; Cheshin O; Shahar OD; Kenig E; Baraz L; Britan-Rosich E; Nagler A; Harris RS; Goldberg M; Willner I; Kotler M
Blood; 2012 Jul; 120(2):366-75. PubMed ID: 22645179
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.
Biasin M; Piacentini L; Lo Caputo S; Kanari Y; Magri G; Trabattoni D; Naddeo V; Lopalco L; Clivio A; Cesana E; Fasano F; Bergamaschi C; Mazzotta F; Miyazawa M; Clerici M
J Infect Dis; 2007 Apr; 195(7):960-4. PubMed ID: 17330785
[TBL] [Abstract][Full Text] [Related]
14. DNA deamination in immunity.
Petersen-Mahrt S
Immunol Rev; 2005 Feb; 203():80-97. PubMed ID: 15661023
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human cytidine deaminase by specific aminoacids involved in the intersubunit interactions.
Vincenzetti S; Quadrini B; Mariani P; De Sanctis G; Cammertoni N; Polzonetti V; Pucciarelli S; Natalini P; Vita A
Proteins; 2008 Jan; 70(1):144-56. PubMed ID: 17640070
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3G Interacts with ssDNA by Two Modes: AFM Studies.
Shlyakhtenko LS; Dutta S; Banga J; Li M; Harris RS; Lyubchenko YL
Sci Rep; 2015 Oct; 5():15648. PubMed ID: 26503602
[TBL] [Abstract][Full Text] [Related]
17. Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.
Solomon WC; Myint W; Hou S; Kanai T; Tripathi R; Kurt Yilmaz N; Schiffer CA; Matsuo H
Nucleic Acids Res; 2019 Aug; 47(14):7676-7689. PubMed ID: 31424549
[TBL] [Abstract][Full Text] [Related]
18. The C-terminal cytidine deaminase domain of APOBEC3G itself undergoes intersegmental transfer for a target search, as revealed by real-time NMR monitoring.
Kamba K; Nagata T; Katahira M
Phys Chem Chem Phys; 2018 Jan; 20(5):2976-2981. PubMed ID: 28905055
[TBL] [Abstract][Full Text] [Related]
19. Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase.
Adolph MB; Webb J; Chelico L
PLoS One; 2013; 8(5):e64196. PubMed ID: 23717565
[TBL] [Abstract][Full Text] [Related]
20. NMR assignments and the identification of the secondary structure of the anti-retroviral cytidine deaminase.
Furukawa A; Nagata T; Habu Y; Sugiyama R; Hayashi F; Yokoyama S; Takaku H; Katahira M
Nucleic Acids Symp Ser (Oxf); 2008; (52):183-4. PubMed ID: 18776314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]